News
Kim Mizar-Stem
Efforts to combat methamphetamine abuse in Oklahoma already have
resulted in restrictions on the sale of pseudoephedrine, a chief
ingredient in meth. Now, some in the state law enforcement community are
hoping to take that battle a step further by making the medicine a
Schedule III drug.